The pandemic caused by COVID-19 continued to affect company activity in 2021. If in 2020, and as a result of the impact caused by the epidemiological crisis, and the subsequent mobility restrictions, an unprecedented fall in demand was reported, 2021 was characterised by a gradual recovery of activity, alongside the improvement of the healthcare indicators and the relaxation of restrictive mobility measures. To sum up, a first quarter still highly marked by the epidemic and a more positive trend since April, was partially halted at the end of the year by the emergence of the omicron variant.
Saba’s rotation activity in 2021 increased by 29% on that of 2020, although it still remained 30% lower than in 2019. With respect to the subscriber figure, it rose by 3% in 2021 with respect to 2020 and was 9% below 2019.
With respect to the main aggregates in 2021 and thanks to the recovery from the second quarter, operating income rose to 234 million euros, up 18% on 2020, although 22% below 2019. EBITDA stood at 103 million euros, up 43% on 2020 and 25% less than in 2019. Saba invested 25 million euros in 2021.